Hazard Information | Back Directory | [Uses]
Mavrilimumab (CAM-3001) is an investigational human IgG4 monoclonal antibody (MAb) targeting GM-CSF receptor alpha which is currently being developed for the treatment of RA. GM-CSF plays a central role in the pathogenesis of rheumatoid arthritis (RA) through the activation, differentiation, and survival of macrophages and neutrophils. |
|
Company Name: |
Biolab Reagents
|
Tel: |
027-65279366 18162686757 |
Website: |
www.biolabreagent.com/ |
|